EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Update

EUDA Health Holdings Limited (NASDAQ:EUDA) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totaling 20,394 shares, a drop of 76.6% from the April 30th total of 87,001 shares. Approximately 0.8% of the company’s shares are short sold. Based on an average daily volume of 53,985 shares, the short-interest ratio is currently 0.4 days.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on EUDA shares. Zacks Research raised EUDA Health from a “strong sell” rating to a “hold” rating in a research note on Friday, May 8th. Weiss Ratings lowered EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research note on Friday, May 8th. Finally, Greenridge Global lowered their price objective on EUDA Health from $120.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, March 9th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $55.00.

EUDA Health Price Performance

Shares of NASDAQ:EUDA traded down $0.71 during trading on Friday, hitting $18.06. The company had a trading volume of 3,762 shares, compared to its average volume of 34,942. The stock has a market cap of $54.00 million, a price-to-earnings ratio of -7.53 and a beta of 0.56. EUDA Health has a one year low of $5.26 and a one year high of $86.00. The company has a fifty day simple moving average of $11.57 and a two-hundred day simple moving average of $27.84.

EUDA Health (NASDAQ:EUDA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported ($0.44) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.20) by $0.76. The business had revenue of $1.92 million for the quarter, compared to the consensus estimate of $3.90 million. On average, equities research analysts anticipate that EUDA Health will post 1.6 earnings per share for the current year.

Institutional Investors Weigh In On EUDA Health

An institutional investor recently bought a new position in EUDA Health stock. Jane Street Group LLC purchased a new position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned about 0.07% of EUDA Health as of its most recent filing with the Securities and Exchange Commission. 4.35% of the stock is currently owned by institutional investors.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.